↓ Skip to main content

How are the Costs of Drug-Related Morbidity Measured?

Overview of attention for article published in Drug Safety, November 2012
Altmetric Badge

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
36 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
How are the Costs of Drug-Related Morbidity Measured?
Published in
Drug Safety, November 2012
DOI 10.2165/11597090-000000000-00000
Pubmed ID
Authors

Hanna Gyllensten, Anna K. Jönsson, Clas Rehnberg, Anders Carlsten

Abstract

Drug-related morbidity has been associated with increased healthcare costs and has been suggested as one of the leading causes of death. Previous reviews have identified heterogeneity in research methods in studies measuring the cost of drug-related morbidity. To date, no attempt has been made to analyse different methods and cost sources used when estimating the costs of drug-related morbidity.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 36 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Bangladesh 1 3%
Unknown 35 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 10 28%
Researcher 7 19%
Student > Bachelor 2 6%
Student > Ph. D. Student 2 6%
Other 2 6%
Other 0 0%
Unknown 13 36%
Readers by discipline Count As %
Medicine and Dentistry 13 36%
Nursing and Health Professions 6 17%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Economics, Econometrics and Finance 1 3%
Agricultural and Biological Sciences 1 3%
Other 2 6%
Unknown 12 33%